KAYFANDA (Ipsen Pharma)

by Pelican Press
1 views 0 minutes read

KAYFANDA (Ipsen Pharma)

KAYFANDA (Active substance: Odevixibat) – Centralised – Authorisation – Commission Decision (2024)6725 of Thu, 19 Sep 2024 – European Medicines Agency (EMA) procedure number: EMEA/H/C/006462/0000


Source link

#KAYFANDA #Ipsen #Pharma

You may also like